Stroke and Vascular Neurology ()

Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry

  • ,
  • Ning Ma,
  • Xiangqun Shi,
  • Lianbo Gao,
  • Yajie Liu,
  • Yongli Li,
  • Dapeng Mo,
  • Feng Gao,
  • Zhongrong Miao,
  • Yan Liu,
  • Zengwu Wang,
  • Yan Wang,
  • Wei Wang,
  • Weihua Wu,
  • Liping Wei,
  • Ping Xu,
  • Jianfeng Zhou,
  • Hao Li,
  • Lei Yang,
  • Yang Hua,
  • Xiaochuan Huo,
  • Ya Peng,
  • Wenhuo Chen,
  • Shengli Chen,
  • Cunfeng Song,
  • Ping Jing,
  • Junfeng Zhao,
  • Liqiang Gui,
  • Zhiming Zhou,
  • Anxin Wang,
  • Zhimin Wang,
  • Yibin Cao,
  • Hongwei Wang,
  • Dong Wang,
  • Peng Zhang,
  • Zhonghua Shi,
  • Haitao Guan,
  • Chao Wang,
  • Long Chen,
  • Xue Wen,
  • Wei Dong,
  • Hui Liang,
  • Chunlei Li,
  • Qingfeng Zhu,
  • Jun Wei,
  • Yun Xu,
  • Xiang Luo,
  • Jin Wu,
  • Zhi Yang,
  • Yongqiang Zhang,
  • Baixue Jia,
  • Yaxuan Sun,
  • Guilian Zhang,
  • Gang Xie,
  • Chong Li,
  • Yuwu Zhao,
  • Wang Bo,
  • Shugui Shi,
  • Yan Xiao,
  • Xiaoxiang Peng,
  • Zaiyu Guo,
  • Ning Guan,
  • Haihua Yang,
  • Gaoting Ma,
  • Xu Tong,
  • Guangxiong Yuan,
  • Deqin Geng,
  • Dapeng Sun,
  • Raynald,
  • Leyuan Wang,
  • Yijiu Lu,
  • Xianjun Wang,
  • Zhenzhong Zhang,
  • Shijun Zhao,
  • Qingshi Zhao,
  • Qingchun Gao,
  • Weirong Li,
  • Xiaojiang Cheng,
  • Xinyu Lu,
  • Dengxiang Wang,
  • Haicheng Yuan,
  • Xuancong Liufu,
  • Wenwu Yang,
  • Wenji Jing,
  • WenWu Peng,
  • Lixin Wang,
  • Wanming Wang,
  • Pu Yuan,
  • Wenbao Liang,
  • Daliang Ma,
  • Xiangdong Xie,
  • Xiangjun Zeng,
  • Fanfan Su,
  • MingZe Chang,
  • Jijun Yin,
  • Hongxia Sun,
  • Yong Bi,
  • Dongqun Li,
  • Zhonglun Chen,
  • Lin Yin,
  • HongKai Qiu,
  • Xiaoya Feng,
  • Tan Lan,
  • Qilong Liang Li Ding,
  • Jianwen Yang,
  • Quanle Zheng,
  • Zhenyun Zhu,
  • Liyue Zhao,
  • Qingbo Meng,
  • Yuqing Wei,
  • Dong Sun,
  • Yongxing Yan,
  • Yadong Yang,
  • Huihong Wang,
  • Xianglin Chen,
  • Juntao Li,
  • Xiang Yong,
  • Mingkai Hu,
  • Yu Xin Wang

DOI
https://doi.org/10.1136/svn-2022-001765

Abstract

Read online

Background and purpose An analysis of the ASTER 2 trial revealed similar final recanalisation levels and clinical outcomes in acute large vessel occlusion (LVO) stroke between stent retrieval (SR) alone as a first-line mechanical thrombectomy (MT) technique (SR alone first-line) and concomitant use of contact aspiration (CA) plus SR as a first-line MT technique (SR+CA first-line). The purpose of the present study was to compare the safety and efficacy of SR+CA first-line with those of SR alone first-line for patients with LVO in China.Methods We conducted the present study by using the data from the ANGEL-ACT registry. We divided the selected patients into SR+CA first-line and SR alone first-line groups. We performed logistic regression and generalised linear models with adjustments to compare the angiographic and clinical outcomes, including successful/complete recanalisation after the first technique alone and all procedures, first-pass successful/complete recanalisation, number of passes, 90-day modified Rankin Scale, procedure duration, rescue treatment and intracranial haemorrhage within 24 hours.Results Of the 1233 enrolled patients, 1069 (86.7%) received SR alone first-line, and 164 (13.3%) received SR+CA first-line. SR+CA first-line was associated with more thrombectomy passes (3 (2–4) vs 2 (1–2); β=1.77, 95% CI=1.55 to 1.99, p<0.001), and longer procedure duration (86 (60–129) min vs 80 (50–122) min; β=10.76, 95% CI=1.08 to 20.43, p=0.029) than SR alone first-line group. Other outcomes were comparable (all p>0.05) between the two groups.Conclusions Patients undergoing SR+CA first-line had more thrombectomy passes and longer procedure duration than patients undergoing SR alone first-line. Additionally, we suggested that SR+CA first-line was not superior to SR alone first-line in final recanalisation level, first-pass recanalisation level and 90-day clinical outcomes in the Chinese population.